Ailomics Therapeutics is now a resident company of Johnson & Johnson Innovation - JLABS, a premier life science incubator program.
JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of
life-enhancing health and wellness solutions to patients around the world. As a leader in innovation, JLABS helps entrepreneurs in
pharmaceutical, medical device, consumer, and health tech bring healthcare solutions to patients and consumers.
Ailomics Therapeutics is a pharmaceutical R&D startup with a pioneering computational and experimental platform to discover novel
targets and develop first-in-class therapeutics for the diseases of significant unmet medical needs.
Learn more: https://jnjinnovation.com/JLABSNavigator/company/Ailomics_Therapeutics
